Open AccessMenAfriVac as an Antitetanus Vaccine
Author(s) -
Ray Borrow,
Yuxiao Tang,
Ahmadu Yakubu,
Prasad S. Kulkarni,
F. Marc LaForce
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ512
Subject(s) - medicine , tetanus , toxoid , incidence (geometry) , vaccination , conjugate vaccine , serology , booster dose , immunization , immunology , antigen , antibody , physics , optics
The group A meningococcal conjugate vaccine, PsA-TT, uses tetanus toxoid (TT) as a carrier protein (PsA-TT). TT as a carrier protein in other conjugate vaccines is known to be immunogenic and generates a robust anti-TT response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom